Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders.
There are three times more cannabis social clubs than McDonald's locations in Spain, so why can patients still not access...
Over 60 percent of medical cannabis patients in a statewide US report say they have used it to replace prescription medications. The analysis conducted in Texas...
Over the past year coronavirus has brought an increase in the demand for immunity-boosting products. Cannabidiol and CBD products are well known for their anti-inflammatory and...
An 81-year-old pensioner, who grew cannabis to treat his chronic kidney disease, has described UK law as “unjust” and “inhumane”. When Cannabis Health first spoke to...
Key stakeholders have indicated a positive step for the UK CBD industry, after meeting with Home Office representatives this week. In a joint statement the British...
With an estimated six million people suffering in the UK, migraine is one of the common chronic pain conditions. A migraine is usually a moderate to...
With novel food regulations coming into force this week there is much discussion in the industry about the various forms of CBD. Most of us know...
The European cannabis market is projected to hit a staggering €3.2 billion by 2025 in a new report. Industry consultants Prohibition Partners expect greater patient access...
Looking forward to gyms reopening in April? Find out how CBD could boost your workout and help you get back to the top of your game....
CBD producers faced with being told to cease trading in the coming days are weighing up their options. Wednesday 31 March marks the deadline for applications...
Leading UK back pain specialists will take part in an expert webinar exploring the role of cannabis medicines in providing relief. One in three people in...